Loading…
A guanidiniocarbonyl-pyrrole functionalized cucurbit[7]uril derivative as a cytomembrane disruptor for synergistic antibacterial therapy
The antibiotic resistance of bacterial membranes poses a significant threat to global public health, highlighting the urgent need for novel therapeutic agents and strategies to combat bacterial membranes. In response, we have developed a novel macrocyclic host molecule ( GCPCB ) based on guanidinioc...
Saved in:
Published in: | Journal of materials chemistry. B, Materials for biology and medicine Materials for biology and medicine, 2024-11, Vol.12 (43), p.1115-1119 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The antibiotic resistance of bacterial membranes poses a significant threat to global public health, highlighting the urgent need for novel therapeutic agents and strategies to combat bacterial membranes. In response, we have developed a novel macrocyclic host molecule (
GCPCB
) based on guanidiniocarbonyl-pyrrole (
GCP
) functionalized cucurbit[7]uril with an aggregation-induced luminescence effect.
GCPCB
exhibits high antimicrobial potency against bacterial membranes, particularly demonstrating strong antibacterial activity against Gram-positive strains of
S. aureus
and Gram-negative strains of
E. coli
. Significantly, due to the strong binding between
GCP
and the bacterial membrane,
GCPCB
can effectively eradicate the bacteria encapsulated within. Furthermore, the formation of a host-guest complex between
GCPCB
and berberine hydrochloride (
BH
) not only enhances synergistic destructive activity against both species of bacteria but also provides a potential supramolecular platform for effective bacterial membrane destruction.
A guanidiniocarbonyl-pyrrole functionalized cucurbit[7]uril derivative as a cytomembrane disruptor has been successfully constructed for synergistic antibacterial therapy. |
---|---|
ISSN: | 2050-750X 2050-7518 |
DOI: | 10.1039/d4tb01840k |